Last reviewed · How we verify
NITROGEN, NF
NITROGEN, NF is a drug developed by UNIVERSAL INDUSTRIAL GASES, INC. It is currently FDA-approved for Persistent pulmonary hypertension of the newborn.
At a glance
| Generic name | NITROGEN, NF |
|---|---|
| Sponsor | UNIVERSAL INDUSTRIAL GASES, INC |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
- Persistent pulmonary hypertension of the newborn
Common side effects
Key clinical trials
- A Phase IB/II Study Evaluating The Safety, Tolerability and Anti-Tumor Activity of Polatuzumab Vedotin in Combination With Rituximab (R) or Obinutuzumab (G) Plus Bendamustine (B) in Relapsed or Refrac (Phase 1)
- A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral (Phase 2)
- Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD) (Phase 2)
- Maximizing Outcome of Multiple Sclerosis Transplantation: "MOST" Trial (Phase 3)
- Autologous Hematopoietic Stem Cell Transplant for Patients With Systemic Sclerosis and Cardiac Dysfunction (Phase 2)
- Phase I/II Study of MLN4924 Alone Followed by Dose-Adjusted EPOCH-Rituximab + MLN4924 With Gene Expression Profiling and Mutational Analysis in Relapsed/Refractory de Novo Diffuse Large B-Cell Lymphom (Phase 1)
- Phase I Study of Bortezomib and Cetuximab Without or With Cisplatin in Combination With Radiation Therapy for Advanced Head and Neck Cancer (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NITROGEN, NF CI brief — competitive landscape report
- NITROGEN, NF updates RSS · CI watch RSS
- UNIVERSAL INDUSTRIAL GASES, INC portfolio CI
Frequently asked questions about NITROGEN, NF
What is NITROGEN, NF?
NITROGEN, NF is a pharmaceutical drug developed by UNIVERSAL INDUSTRIAL GASES, INC, indicated for Persistent pulmonary hypertension of the newborn.
What is NITROGEN, NF used for?
NITROGEN, NF is indicated for Persistent pulmonary hypertension of the newborn.
Who makes NITROGEN, NF?
NITROGEN, NF is developed and marketed by UNIVERSAL INDUSTRIAL GASES, INC (see full UNIVERSAL INDUSTRIAL GASES, INC pipeline at /company/universal-industrial-gases-inc).
What development phase is NITROGEN, NF in?
NITROGEN, NF is FDA-approved (marketed).
Related
- Manufacturer: UNIVERSAL INDUSTRIAL GASES, INC — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Persistent pulmonary hypertension of the newborn
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing